case_images: PMC10863383_01
case_images: CT chest of case 1 obtained in June 2022 showing numerous bilateral pulmonary metastases.. Abbreviation: CT, computed tomography.
case_images: 10.1177_23247096241231641-fig1.jpg
case_images: PMC10863383_01_10.1177_23247096241231641-fig1.jpg
case_images: fig1-23247096241231641
case_images: Subsequent computed tomography (CT) chest showed progression with numerous bilateral lung metastases (Figure 1).
case_images: Repeat CT chest of Case 1 obtained in August 2022 after approximately 1 month on belzutifan 120 mg daily, showing a remarkable disease response.. Abbreviation: CT, computed tomography.
case_images: 10.1177_23247096241231641-fig2.jpg
case_images: PMC10863383_01_10.1177_23247096241231641-fig2.jpg
case_images: fig2-23247096241231641
case_images: A repeat CT chest in August showed a remarkable response to belzutifan (Figure 2).
case_images: PMC10863383_02
case_images: CT chest of case 2 in April 2022 showing large pleural-based lung metastases and malignant pleural effusion: (A) axial view and (B) coronal view.. Abbreviation: CT, computed tomography.
case_images: 10.1177_23247096241231641-fig3.jpg
case_images: PMC10863383_02_10.1177_23247096241231641-fig3.jpg
case_images: fig3-23247096241231641
case_images: CT chest in April 2022 showed a large pleural-based lung metastases and malignant pleural effusion (Figure 3).
case_images: CT chest of case 2 obtained 1 year later showing a remarkable response with no progression: (A) axial view and (B) coronal view.. Abbreviation: CT, computed tomography.
case_images: 10.1177_23247096241231641-fig4.jpg
case_images: PMC10863383_02_10.1177_23247096241231641-fig4.jpg
case_images: fig4-23247096241231641
case_images: Her disease has maintained a strong response with no progression seen on a repeat CT chest 1.5 years later (Figure 4).